Search JIM
Advanced Search
Journal of Chinese Integrative Medicine ›› 2003, Vol. 1 ›› Issue (3): 221-225.doi: 10.3736/jcim20030324
Previous Articles Next Articles
Xin-yi Chen(
), Jiang-tao Liu
CLC Number:
| [1] |
Chevillard S, Pouillart P, Beldjord C , et al. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy[J]. Cancer, 1996,77(2):292-300
doi: 10.1002/(ISSN)1097-0142 |
| [2] | Decker DA, Morris LW, Levine AJ , et al. Immunohistochemical analysis of P-glycoprotein expression in breast cancer:clinical correlations[J]. Ann Clin Lab Sci, 1995,25(1):52-59 |
| [3] |
Cole SP, Bhardwaj G, Gerlach JH , et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line[J]. Science, 1992,258(5088):1650-1654
doi: 10.1126/science.1360704 |
| [4] |
Versantvoort CH, Withoff S, Broxterman HJ , et al. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance[J]. Int J Cancer, 1995,61(3):375-380
doi: 10.1002/(ISSN)1097-0215 |
| [5] |
Zaman GJ, Flens MJ, Vanleusden MR , et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump[J]. Proc Natl Acad Sci, 1994,91(19):8822-8826
doi: 10.1073/pnas.91.19.8822 pmid: 7916458 |
| [6] | Brock I, Hipfner DR, Nielsen BS , et al. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16(etoposide)-selected H69 small cell lung cancer cells[J]. Cancer Res, 1995,55(3):459-462 |
| [7] | Versantvoort CH, Broxterman HJ, Bagrij T , et al. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein[J]. Br J Cancer, 1995,72(1):89 |
| [8] | Scheper RJ, Broxterman HJ, Scheffer GL , et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance[J]. Cancer Res, 1993,53(7):1475-1479 |
| [9] |
Withoff S, Jong De S, Vries De EG , et al. Human DNA topoisomerase Ⅱ: biochemistry and role in chemotherapy resistance[J]. Anticancer Res,, 1996,16(4A):1867-1880
pmid: 8712715 |
| [10] |
Vassetzky YS, Alghisi GC, Gasser SM . DNA topoisomerase Ⅱ mutations and resistance to anti-tumor drugs[J]. Bioessays, 1995,17(9):767-774
doi: 10.1002/bies.950170906 pmid: 8763829 |
| [11] | 许文林, 敖忠芳, 陈玉心 , 等. 汉防己甲素对柔红霉素和长春新碱增效作用的实验研究[J]. 中华血液学杂志, 1994,15(5):256-257 |
| [12] | 夏薇, 敖忠芳, 朱广荣 . 一种有效的肿瘤耐药逆转剂——汉防己甲素逆转白血病耐药的实验研究[J]. 南京医科大学学报, 1995,15(3):543-546 |
| [13] | 潘启超, 田晖 . 多种中药单体逆转肿瘤多药耐药性[J]. 科学通报, 1995,40(20):1901-1904 |
| [14] |
敖忠芳, 夏薇 . 汉防己甲素逆转白血病细胞耐药的研究[J]. 中华血液学杂志, 1995,16(5):235-237
doi: 10.1007/BF02007173 |
| [15] |
叶祖光, 孙爱续, 李兰芳 , 等. 汉防己甲素对阿霉素或长春新碱耐药株人癌细胞的逆转抗药性作用[J]. 中国中药杂志, 1996,21(6):369-371
doi: 10.1007/BF02951625 |
| [16] | 何琪杨, 孟凡宏, 张鸿卿 . 粉防已碱和蝙蝠葛碱减低抗三尖杉酯碱的人白血病HL60细胞对阿霉素的抗性[J]. 中国药理学报, 1996,17(2):179-181 |
| [17] | 田晖, 潘启超 . 双苄基异喹啉生物碱蝙蝠葛碱与蝙蝠葛苏林碱逆转多药耐药性的比较研究[J]. 癌症, 1996,15(6):410-414 |
| [18] | 叶祖光, 孙爱续, 李春英 , 等. 双苄基异喹啉化合物Ys-96对阿霉素或长春新碱耐药株人癌细胞的逆转抗药性作用[J]. 中国中药杂志, 1998,23(7):427-428 |
| [19] | Shiraishi N, Akiyama S, Nakagawa M , et al. Effect of bisbenzylisoquinoline(biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells[J]. Cancer Res, 1987,47(9):2413-2416 |
| [20] | Akiyama S, Cornwell MM, Kuwano M , et al. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog[J]. Mol Pharmacol, 1988,33(2):144-147 |
| [21] | Chen G, Ramachandran C, Krishan A , et al. Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein[J]. Cancer Res, 1993,53(11):2544-2547 |
| [22] | 谢佐福, 沈世仁 . 川芎嗪和羟基脲对阿霉素K562细胞株DNA合成的影响[J]. 中华医学杂志, 1993,73(9):559-560 |
| [23] | 胡艳平, 刘健, 王庆端 , 等. 川芎嗪和维拉帕米纠正阿霉素对小鼠艾氏腹水癌的抗药性[J]. 药学学报, 1993,28(1):75-78 |
| [24] | 王庆端, 江金花, 孙文欣 , 等. 川芎嗪逆转肿瘤抗药性与谷胱苷肽过氧化物酶的关系[J]. 河南医科大学学报, 1997,32(4):50-52 |
| [25] |
梁蓉, 杨平地, 陈协群 . 川芎嗪和(或)环孢素A对HL-60/HT细胞耐药的逆转[J]. 中华内科杂志, 1999,38(4):260-261
doi: 10.3760/j.issn:0578-1426.1999.04.016 |
| [26] | 梁蓉, 杨平地, 陈协群 , 等. 川芎嗪对白血病HL-60/VCR细胞多药耐药的逆转及其机制研究[J]. 中华血液学杂志, 1999,20(6):323-324 |
| [27] | 张振玉, 王崇文, 祝金泉 , 等. 川芎嗪及联用化疗药物对胃癌细胞杀伤作用的研究[J]. 中国现代医学杂志, 1999,9(1):68-69 |
| [28] | 胡凯文, 陈信义 . 中药活性成分抗耐药肿瘤细胞体外筛选研究[J]. 中国医药学报, 1998,13(2):10-12 |
| [29] | 胡凯文, 郑洪霞, 齐静 , 等. 浙贝母碱逆转白血病细胞多药耐药的研究[J]. 中华血液学杂志, 1999,20(12):650-651 |
| [30] | 潘宏铭, 胡汛, 吴金民 , 等. 大肠癌抗多药性细胞株SW116/DOX的建立及茶多酚复合体的逆转作用研究[J]. 肿瘤, 1997,17(4):213-216 |
| [31] | 胡先珍, 张友会 . 绿茶儿茶素对小鼠细胞免疫功能的增强作用[J]. 中华微生物学和免疫学杂志, 1991,11(2):97-99 |
| [32] |
白月辉, 黄世林 . 雄黄对NB4及HL-60细胞的促凋亡作用[J]. 中华血液学杂志, 1998,19(9):477-480
doi: 10.3760/j:issn:0253-2727.1998.09.009 |
| [33] | 张晨, 黄世林 . 雄黄抗白血病细胞多药耐药及其凋亡诱导关系的研究[J]. 中国中医基础医学杂志, 1999,5(12):40-42 |
| [34] | 张文卿, 刘叙仪, 刘海英 , 等. 中药R1对耐阿霉素人乳腺癌细胞系(MCF-7/Adr)多药耐受的逆转作用[J]. 中药药理与临床, 1994,10(5):16-21 |
| [35] | 张文卿, 刘叙仪, 韩复生 , 等. 中药方剂R1对耐阿霉素人乳腺癌细胞P糖蛋白表达的影响[J]. 中药药理与临床, 1996,12(1):18-22 |
| [36] | 刘叙仪, 孟松娘, 杨敬贤 , 等. 中药R3(补骨脂抽提剂)对耐阿霉素人乳腺癌细胞MCF-7/Adr多药耐药的逆转[J]. 中国肿瘤临床, 1997,24(5):325-330 |
| [1] | Ming-min Xu, Pei Guo, Qing-yu Ma, Xuan Zhou, Yu-long Wei, Lu Wang, Yue Chen, Yu Guo. Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression? A systematic review and meta-analysis. Journal of Integrative Medicine, 2022, 20(4): 305-320. |
| [2] | Ting-ting Lu, Cun-cun Lu, Mei-xuan Li, Li-xin Ke, Hui Cai, Ke-hu Yang. Reporting and methodological quality of meta-analyses of acupuncture for patients with migraine: A methodological investigation with evidence map. Journal of Integrative Medicine, 2022, 20(3): 213-220. |
| [3] | Witoo Dilokthornsakul, Ramanya Kosiyaporn, Rattanamanee Wuttipongwaragon, Piyameth Dilokthornsakul. Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies. Journal of Integrative Medicine, 2022, 20(2): 114-125. |
| [4] | Jun-peng Yao, Li-ping Chen, Xian-jun Xiao, Ting-hui Hou, Si-yuan Zhou, Ming-min Xu, Kai Wang, Yu-jun Hou, Lin Zhang, Ying Li. Effectiveness and safety of acupuncture for treating functional constipation: An overview of systematic reviews. Journal of Integrative Medicine, 2022, 20(1): 13-25. |
| [5] | Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560. |
| [6] | Yi Yuan, Rui-Ting Wang, Jun Xia, Hui-Juan Cao. Interventions for preventing influenza: an overview of Cochrane systematic reviews and a Bayesian network meta-analysis. Journal of Integrative Medicine, 2021, 19(6): 503-514. |
| [7] | Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466. |
| [8] | Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326. |
| [9] | Liang Dai, Ka Kei Chan, Jian-chun Mao, Yu Tian, Jun-hua Gu, Jun Zhou, Linda L.D. Zhong. Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(6): 478-491. |
| [10] | Qing-lan Wang, Yan-yan Tao, Hong-dong Xie, Cheng-hai Liu, Ping Liu. Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis. Journal of Integrative Medicine, 2020, 18(6): 505-513. |
| [11] | Ming-sheng Lyu, De-ying Li, Shao-zhong Zhou, Cheng-jun Ban, Jun Yan. Adult-onset Still's disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine, 2020, 18(6): 530-534. |
| [12] | Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394. |
| [13] | Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384. |
| [14] | Xian-jun Xiao, Lei-xiao Zhang, Yun-zhou Shi, Jun-peng Yao, Wei Cao, Ying Liu, Zi-hao Zou, Si-yuan Zhou, Ming-ling Chen, Chun-xiao Li, Qian-hua Zheng, Ying Li. Cupping therapy for patients with chronic urticaria: A systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(4): 303-312. |
| [15] | Dong-dong Yu, Liang-zhen You, Wan-qiu Huang, Hui Cao, Fan-jing Wang, Xiu-qin Tang, Zhao-hui Fang, Guo-ming Shen, Yu-xiang Guan. Effects of traditional Chinese exercises on blood glucose and hemoglobin A1c levels in patients with prediabetes: A systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(4): 292-302. |
|
沪公网安备31010602003416号 沪ICP备18017633号-3